MedTrace Logo

Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis

NCT03985020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-09-05

No results posted yet for this study

Summary

In order to determine whether rebaudioside consumption can be used as a treatment for adolescents with Non-alcoholic Fatty Liver Disease (NAFLD) by demonstrating a decrease in alanine aminotransferase (ALT) levels participants will be randomized to receive one of three 8-week liquid diet interventions:

1. Standard of care
2. Water delivery
3. Water with Rebaudioside (stevia natural sweetener)

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

OTHER

Stevia Intervention

We will use commercially available stevia sweetened soft drink Zevia.

OTHER

Water Intervention

Bottled Water

Sponsors & Collaborators

Principal Investigators

  • Tania Mitsinikos, MD · Children's Hospital Los Angeles

  • Rohit Kohli, MBBS, MS · Children's Hospital Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-26
Primary Completion
2024-08-01
Completion
2024-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03985020 on ClinicalTrials.gov